ARA-290 (cibinetide)

Structure

Regulatory & access status

ARA-290 (cibinetide) is an investigational compound: it has been studied in clinical trials but has no FDA approval.

Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.

How much research exists on ARA-290 (cibinetide)?

PubMed indexes 14 papers mentioning ARA-290 (cibinetide) in the title or abstract, 7 of them from the last five years and 1 tagged as clinical trials (search run October 19, 2026; repeat the search).

Most relevant recent papers

• Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis. — Sci Rep, 2017
• Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation. — Cell Transplant, 2021
• The time to develop treatments for diabetic neuropathy. — Expert Opin Investig Drugs, 2021 · review
• Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand. — Transplantation, 2020
• A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema. — J Clin Med, 2020
• Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. — Invest Ophthalmol Vis Sci, 2017 · clinical trial

Registered clinical studies

ClinicalTrials.gov lists 4 studies with ARA-290 (cibinetide) as an intervention (see all). Most recent:

• Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis — NCT02039687 · Phase 2 · completed · started 2014-01
• ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes) — NCT01933529 · Phase 2 · unknown · started 2013-10
• Cognitive and Neural Effects of ARA290 — NCT02070783 · Phase 1/Phase 2 · completed · started 2012-02
• The Use of ARA290 for the Treatment of Diabetic Macular Oedema — NCT06626971 · Phase 2 · terminated · started 2016-04

What the evidence does not show

• Paper counts measure research attention, not whether ARA-290 works or is safe.
• No FDA review of any "research use only" product's identity, purity, sterility or dose.

Research suppliers that list ARA-290

26 vendors in our directory listed a product matching ARA-290 in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.

• Ascension PeptidesCatalog item: “ARA-290 10mg”
• Atomik LabzCatalog item: “BULK PACK ARA-290 – 10mg (10 VIALS)”
• Backroad AminosCatalog item: “ARA-290 30mg”
• BioGenix PeptidesCatalog item: “ARA-290 10mg”
• BioLongevity LabsCatalog item: “ARA-290 (15mg)”
• Biotech PeptidesCatalog item: “ARA-290 (16mg)”
• Bulk Peptide SupplyCatalog item: “ARA-290 10 mg”
• Core PeptidesCatalog item: “ARA-290 – 16MG”
• Eros PeptidesCatalog item: “ARA-290 20MG”
• Evolve BioPepCatalog item: “ARA-290 16 mg”
• Ion PeptideCatalog item: “ARA-290”
• Liberty PeptidesCatalog item: “ARA-290 (16mg)”
• Modern AminosCatalog item: “ARA-290”
• Paramount PeptidesCatalog item: “ARA-290 (16mg)”
• Peptide CraftersCatalog item: “ARA-290 (16mg)”
• Plum Labs ResearchCatalog item: “ARA-290 10mg”
• ProtideHealthCatalog item: “ARA-290 16mg”
• Pure Lab PeptidesCatalog item: “Ara-290 16mg”
• Royal PeptidesCatalog item: “ARA-290 30mgx10vials”
• San Diego PeptidesCatalog item: “ARA-290 (Cibinetide)”
• Science.bioCatalog item: “ARA-290 – Aliquot, 5mg”
• Southern AminosCatalog item: “ARA-290 10mg”
• Sunrise BioResearchCatalog item: “ARA-290 10mg x 10vials, 100mg”
• Swiss ChemsCatalog item: “Cibinitide ARA-290 16mg”
• Verified PeptidesCatalog item: “ARA-290 Peptide (12MG)”
• Xcel PeptidesCatalog item: “ARA-290”

Prices per mg, where we could verify them, are on our price comparison.

ARA-290 reconstitution math

Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.

ARA-290 FAQ

Related compounds

OxytocinVIPCerebrolysinDSIPSemaxSelankAdamaxDihexaAll cognitive, neuro & sleep